| Name | Title | Contact Details |
|---|
Huntsville Hospital is an 881-bed hospital that was established in Huntsville, Alabama in 1895. A community-based, not-for-profit institution, Huntsville Hospital is the second largest hospital in Alabama and the sixth largest publicly owned hospital system in the nation. Huntsville Hospital employs nearly 7,000 employees and has a Medical Staff with more than 750 physicians. Huntsville Hospital serves as the major referral hospital and trauma center for patients throughout the Tennessee Valley and is a teaching facility for UAB`s Family Practice and Internal Medicine Residency Programs.
Eden Health eliminates the hassle of healthcare for employers and their employees. We`re a new kind of doctor`s office that combines a private primary care practice, 24/7 telemedicine, and personalized insurance navigation into one simple platform. Eden provides an experience that employees love and saves employers money with seamless, data-driven healthcare.
Westborough Behavioral Healthcare Hospital is a mental health care hospital that provides consistent levels of excellent service and an attitude of caring expressed by the entire organization.
Sundial believes in health, happiness and personal well-being. Our cannabis is carefully cultivated for modern consumers—people looking for a natural alternative that fits todays active lifestyles. We are a licensed cannabis producer based in Alberta. We combine tried-and-true heartland farming with innovative horticultural techniques to grow a select range of cannabis strains. Our focus is on consistency—a pure cannabis experience that our customers can trust and count on.
Sernova Corp. is a clinical-stage biotechnology company that is developing its Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells, for the treatment of chronic diseases such as insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. On implantation, the Cell Pouch forms a natural vascularized tissue environment in the body for the long-term survival and function of therapeutic cells that release essential factors absent or deficient in patients with certain chronic diseases. Sernova is also advancing a proprietary technology to shield therapeutic cells from immune system attacks with the goal to eliminate the need for chronic, systemic immunosuppression. In May 2022, the Company announced a global strategic partnership with Evotec, providing Sernova with a potentially unlimited supply of insulin-producing islet cells to treat patients with insulin-dependent diabetes (type 1 and type 2). Sernova continues to progress additional development programs utilizing its Cell Pouch System: a cell therapy for hypothyroid disease resulting from thyroid gland removal and an ex-vivo lentiviral Factor VIII gene therapy for hemophilia A.